Your browser doesn't support javascript.
loading
Automatized self-supervised learning for skin lesion screening.
Useini, Vullnet; Tanadini-Lang, Stephanie; Lohmeyer, Quentin; Meboldt, Mirko; Andratschke, Nicolaus; Braun, Ralph P; Barranco García, Javier.
Afiliação
  • Useini V; Department of Mechanical and Process Engineering, ETH Zurich, Leonhardstrasse 21, 8092, Zurich, Switzerland.
  • Tanadini-Lang S; Department of Radiation Oncology, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
  • Lohmeyer Q; Department of Radiation Oncology, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
  • Meboldt M; University of Zurich, Rämistrasse 71, 8006, Zurich, Switzerland.
  • Andratschke N; Department of Mechanical and Process Engineering, ETH Zurich, Leonhardstrasse 21, 8092, Zurich, Switzerland.
  • Braun RP; Department of Mechanical and Process Engineering, ETH Zurich, Leonhardstrasse 21, 8092, Zurich, Switzerland.
  • Barranco García J; Department of Radiation Oncology, University Hospital Zurich, Rämistrasse 100, 8091, Zurich, Switzerland.
Sci Rep ; 14(1): 12697, 2024 06 03.
Article em En | MEDLINE | ID: mdl-38830890
ABSTRACT
Melanoma, the deadliest form of skin cancer, has seen a steady increase in incidence rates worldwide, posing a significant challenge to dermatologists. Early detection is crucial for improving patient survival rates. However, performing total body screening (TBS), i.e., identifying suspicious lesions or ugly ducklings (UDs) by visual inspection, can be challenging and often requires sound expertise in pigmented lesions. To assist users of varying expertise levels, an artificial intelligence (AI) decision support tool was developed. Our solution identifies and characterizes UDs from real-world wide-field patient images. It employs a state-of-the-art object detection algorithm to locate and isolate all skin lesions present in a patient's total body images. These lesions are then sorted based on their level of suspiciousness using a self-supervised AI approach, tailored to the specific context of the patient under examination. A clinical validation study was conducted to evaluate the tool's performance. The results demonstrated an average sensitivity of 95% for the top-10 AI-identified UDs on skin lesions selected by the majority of experts in pigmented skin lesions. The study also found that the tool increased dermatologists' confidence when formulating a diagnosis, and the average majority agreement with the top-10 AI-identified UDs reached 100% when assisted by our tool. With the development of this AI-based decision support tool, we aim to address the shortage of specialists, enable faster consultation times for patients, and demonstrate the impact and usability of AI-assisted screening. Future developments will include expanding the dataset to include histologically confirmed melanoma and validating the tool for additional body regions.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Detecção Precoce de Câncer / Aprendizado de Máquina Supervisionado / Melanoma Limite: Female / Humans / Male Idioma: En Revista: Sci Rep Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Detecção Precoce de Câncer / Aprendizado de Máquina Supervisionado / Melanoma Limite: Female / Humans / Male Idioma: En Revista: Sci Rep Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Suíça